Mesenchymal stem cells offer novel treatment approach for Crohn’s disease fistula

(Mary Ann Liebert, Inc./Genetic Engineering News) A growing body of clinical evidence shows that transplantation of a patient’s own mesenchymal stem cells (MSCs) to achieve a cure and prevent recurrent of Crohn’s disease-related fistula can be a safe and effective addition to surgery.